Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426009361?dgcid=rss_sd_all
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426009361?dgcid=rss_sd_all
“Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.” Annals of Oncology.
@article{article88398,
title = {Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426009361?dgcid=rss_sd_all}
}